Pregnancy Insulin Calculator (Gestational Diabetes)

Medically reviewed by Dr. Chhaya Makhija, MD, DipABLM — October 2026

Educational overview of insulin use in pregnancy for gestational and pre-existing diabetes. All estimates shown are for reference only and must be supervised by an OB or maternal-fetal medicine specialist.

🤰 Pregnancy Insulin Reference Estimator

Shows educational reference estimates only. All insulin decisions in pregnancy must be made with your OB or MFM specialist.

🚨 Reminder: These are educational reference values only. Insulin in pregnancy must be prescribed and supervised by your OB or MFM team — never self-adjusted.

Reference Estimate

—Est. TDD range
units/day
—Basal ~40–50%
units/day
—Fasting BG target
(ADA pregnancy)
—1-hr postmeal target
(ADA pregnancy)
Notes for this trimester:

Calculating Insulin Doses in Pregnancy

There is no single average insulin dose in pregnancy — requirement scales with weight, diabetes type and trimester. As reference points: published starting doses for gestational diabetes range from about 0.5 to 1.0 units/kg/day depending on the protocol and trimester, while type 1 pregnancies commonly run 0.6–0.7 units/kg/day in the first trimester, rising to 0.9–1.1 by the third. The estimator below applies these ranges to your weight.

Insulin requirements change dramatically across the three trimesters of pregnancy. Understanding these changes helps patients engage meaningfully with their obstetric diabetes team — it does not replace that team.

Trimester-Specific Dose Changes

TrimesterInsulin SensitivityTypical Dose FactorKey Driver
1st (wks 1–12)Increased or unchanged0.6–0.7 u/kg (T1D)Nausea may reduce food intake; some need less insulin
2nd (wks 13–27)Decreasing0.7–0.9 u/kg (T1D)Placental hormones begin rising
3rd (wks 28–40)Significantly reduced0.9–1.1 u/kg (T1D)HPL, progesterone, cortisol peak — strong insulin resistance
PostpartumRapidly normalisesReduce ~50% immediatelyPlacenta delivered — insulin-blocking hormones clear rapidly

Sources: ADA Standards of Care 2026, Section 15; ACOG Practice Bulletin 201; García-Patterson 2010 (requirement trajectory).

Blood Glucose Targets in Pregnancy (ADA 2026)

  • Fasting: < 95 mg/dL (5.3 mmol/L)
  • 1-hour post-meal: < 140 mg/dL (7.8 mmol/L)
  • 2-hour post-meal: < 120 mg/dL (6.7 mmol/L)

These are tighter than non-pregnant targets. More frequent monitoring (6–8 checks/day or continuous glucose monitoring) is typically required. CGM is increasingly used and recommended for pregnant women with Type 1 and Type 2 diabetes. Outside pregnancy, dosing tools for every regimen are in our insulin calculators for every regimen.

DKA risk is elevated in pregnancy. Pregnant women with Type 1 diabetes can develop DKA at lower blood glucose levels than non-pregnant adults (so-called "euglycemic DKA"). Any illness, vomiting, or unusual ketone readings during pregnancy must be evaluated urgently by the obstetric team — do not manage at home without guidance.

Sources & References

  1. American Diabetes Association. Standards of Care in Diabetes — 2026. Section 15: Management of Diabetes in Pregnancy. Diabetes Care. 2026;49(Suppl 1):S321. Link
  2. ACOG Practice Bulletin No. 201. "Pregestational Diabetes Mellitus." Obstet Gynecol. 2018;132(6):e228–e248.
  3. Blumer I et al. "Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline." J Clin Endocrinol Metab. 2013;98(11):4227–4249.
  4. García-Patterson A, Gich I, Amini SB, Catalano PM, de Leiva A, Corcoy R. Insulin requirements throughout pregnancy in women with type 1 diabetes mellitus: three changes of direction. Diabetologia. 2010;53(3):446–451. Link
  5. Wyckoff JA, Lapolla A, et al. Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline. J Clin Endocrinol Metab. 2025;110(9):2405–2452. Link
  6. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 190: Gestational Diabetes Mellitus. Obstet Gynecol. 2018;131(2):e49–e64. Link

Written by Ryan Mitchell · Last updated: October 2026

Frequently Asked Questions: Pregnancy Insulin Calculator (Gestational Diabetes)

In the 1st trimester, sensitivity often increases slightly — some women with pre-existing Type 1 need less insulin, especially if nausea reduces food intake, and requirements are at their least stable in the first 16 weeks. From week 16 they climb steeply as placental hormones (HPL, progesterone, cortisol) rise — about 4–5% per week, peaking around week 37 — so late-pregnancy doses run well above early-pregnancy ones. Immediately after delivery, insulin sensitivity rapidly returns as the placenta clears — dose must be reduced immediately to avoid severe hypoglycemia.

Yes. Insulin does not cross the placenta in significant amounts and is the preferred treatment for diabetes in pregnancy. Rapid-acting analogs lispro (Humalog) and aspart (NovoLog) are preferred over regular insulin in pregnancy, and detemir carries the strongest basal-analog safety evidence — but detemir (Levemir) was discontinued in the US at the end of 2024, which leaves NPH as the classic basal alternative; glargine is usually continued rather than newly started. Uncontrolled blood glucose during pregnancy carries far greater risks to the fetus than insulin therapy itself. Your obstetric team will recommend the specific insulin type appropriate for your pregnancy.

ADA targets for diabetes in pregnancy: fasting BG < 95 mg/dL (5.3 mmol/L), 1-hour post-meal < 140 mg/dL (7.8 mmol/L), 2-hour post-meal < 120 mg/dL (6.7 mmol/L). These are significantly tighter than non-pregnancy targets. Achieving them requires intensive monitoring — often 6–8 checks/day or continuous glucose monitoring — and frequent dose adjustments. Your OB or MFM team will set personalised targets for your pregnancy based on your specific history.

Gestational diabetes mellitus (GDM) is glucose intolerance first diagnosed during pregnancy. Many cases — perhaps 70–80% — can be managed with diet and lifestyle changes alone. When diet fails to achieve glucose targets after 1–2 weeks, insulin is the preferred first pharmacological treatment (oral agents like metformin and glyburide are used in some protocols but are not FDA-approved for GDM). The decision to start insulin, the starting dose, and the monitoring plan must come from your obstetric team.

After delivery, placental hormones clear rapidly. Women with pre-existing Type 1 or Type 2 diabetes must reduce their insulin dose immediately — often by 50% or more — to avoid severe postpartum hypoglycemia. This transition is managed by the obstetric and endocrine team. Women with GDM typically no longer need insulin after delivery but have a 50% lifetime risk of developing Type 2 diabetes and should be screened with a post-partum glucose test at 4–12 weeks and annually thereafter.

Insulin in pregnancy must be managed by an OB/GYN or maternal-fetal medicine specialist. This page is for educational reference only. Never self-adjust insulin during pregnancy — the stakes for both mother and baby are too high.